Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 22;44(7):115933.
doi: 10.1016/j.celrep.2025.115933. Epub 2025 Jul 1.

Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans

Affiliations
Free article

Presentation of immunoregulatory sialoglycans on T cells is divergent between mice and humans

Fauzia N Izzati et al. Cell Rep. .
Free article

Abstract

Glycans are emerging as important regulators of T cell function but remain poorly characterized across the functionally distinct populations that exist in vivo. Here, we couple single-cell analysis technologies with soluble lectins and chemical probes to interrogate glycosylation patterns on major T cell populations across mouse and human tissues. Our analysis focused on terminal glycan epitopes with immunomodulatory functions, including sialoglycan ligands for Siglecs. We demonstrate that glycosylation patterns are diverse across the resting murine T cell repertoire and dynamically remodeled in response to stimulation. Surprisingly, we find that human T cell populations do not share the same glycoprofiles or glycan remodeling dynamics as their murine counterparts. We show that these differences can be explained by divergent regulation of glycan biosynthesis pathways between the species. These results highlight fundamental glycophysiological differences between mouse and human T cells and reveal features that are critical to consider for glycan-targeted therapies.

Keywords: CP: Cell biology; CP: Immunology; T cells; adaptive immunity; glycan biosynthesis; glycocalyx; glycosylation; sialic acid.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests L.J.E. is listed as a co-inventor on a patent application (US20230293711A1) describing aspects of sialic acid removal on T cells as a human therapy. While this is not directly related to the content of this present work, it is being disclosed to be maximally transparent.

Substances

LinkOut - more resources